$0.653000
0.045.66%
Last update: 8:51 AM
15 minutes delayed
Bolt Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bolt Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.56 | $-0.48 | -16.7 % |
Mar 2024 | 2024-05-14 | $-0.28 | $-0.51 | 45.1 % |
Dec 2023 | 2024-03-21 | $-0.47 | $-0.48 | 2.08 % |
Sep 2023 | 2023-11-09 | $-0.43 | $-0.50 | 14.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $1.27M | $891.50K | 43.0 % |
Mar 2024 | 2024-05-14 | $5.27M | $2.06M | 156.0 % |
Dec 2023 | 2024-03-21 | $2.09M | $1.71M | 22.2 % |
Sep 2023 | 2023-11-09 | $2.53M | $1.72M | 47.0 % |
Bolt Biotherapeutics (BOLT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.56, which missed the estimate of $-0.48.
The Actual Revenue was $1.3M, which beat the estimate of $891.5K.
Browse earnings estimates, EPS, and revenue on all stocks.